Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma. (2020)
Attributed to:
Development of clinically viable, calibrated FMRI
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ctro.2020.03.001
PubMed Identifier: 32211520
Publication URI: http://europepmc.org/abstract/MED/32211520
Type: Journal Article/Review
Volume: 22
Parent Publication: Clinical and translational radiation oncology
ISSN: 2405-6308